Association of Body Mass Index with Survival in Asian Patients with Colorectal Cancer

被引:8
|
作者
Lee, Sangwon [1 ]
Lee, Dong Hee [2 ]
Lee, Jae-Hoon [3 ]
Shin, Su-Jin [4 ]
Lee, Hye Sun [5 ]
Park, Eun Jung [2 ]
Baik, Seung Hyuk [2 ]
Lee, Kang Young [6 ]
Kang, Jeonghyun [2 ]
机构
[1] Yonsei Univ, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, 211 Eonju Ro, Seoul 06273, South Korea
[3] Yonsei Univ, Gangnam Severance Hosp, Dept Nucl Med, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Gangnam Severance Hosp, Dept Pathol, Coll Med, Seoul, South Korea
[5] Yonsei Univ, Biostat Collaborat Unit, Coll Med, Seoul, South Korea
[6] Yonsei Univ, Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2022年 / 54卷 / 03期
关键词
Thinness; Overweight; Obese; Survival; Colorectal neoplasms; OBESITY PARADOX; MORTALITY; DIAGNOSIS; RISK; IMPACT;
D O I
10.4143/crt.2021.656
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The clinical significance of body mass index (BMI) on long-term outcomes has not been extensively investigated in Asian patients with colorectal cancer (CRC). This study aims to describe the association between BMI and survival, plus providing BMI cutoff value for predicting prognosis in CRC patients. Materials and Methods A total of 1,182 patients who had undergone surgery for stage I-III CRC from June 2004 to February 2014 were included. BMI was categorized into four groups based on the recommendation for Asian ethnicity. The optimal BMI cutoff value was determined to maximize overall survival (OS) difference. Results In multivariable analysis, underweight BMI was significantly associated with poor OS (hazard ratio [HR], 2.38; 95% confidence interval [CI], 1.55 to 3.71; p < 0.001) and obese BMI was associated with better OS (HR, 0.72; 95% CI, 0.53 to 0.97; p=0.036) compared with the normal BMI. Overweight and obese BMI were associated with better recurrence-free survival (HR, 0.64; 95% CI, 0.42 to 0.99; p=0.046 and HR, 0.58; 95% CI, 0.38 to 0.89; p=0.014, respectively) compared with the normal BMI group. BMI cutoff value was 20.44 kg/m(2). Adding the BMI cutoff value to cancer staging could increase discriminatory performance in terms of integrated area under the curve and Harrell's concordance index. Conclusion Compared to normal BMI, underweight BMI was associated with poor survival whereas obese BMI was associated with better survival. BMI cutoff value of 20.44 kg/m(2) is a useful discriminator in Asian patients with CRC.
引用
收藏
页码:860 / 872
页数:13
相关论文
共 50 条
  • [31] Body mass index and survival of patients with lymphoma
    Chihara, Dai
    Larson, Melissa C.
    Robinson, Dennis P.
    Thompson, Carrie A.
    Maurer, Matthew J.
    Casulo, Carla
    Pophali, Priyanka
    Link, Brian K.
    Habermann, Thomas M.
    Feldman, Andrew L.
    Flowers, Christopher R.
    Cerhan, James R.
    Morton, Lindsay M.
    LEUKEMIA & LYMPHOMA, 2021, 62 (11) : 2671 - 2678
  • [32] Association of body mass index (BMI) with overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC) who received targeted therapies (TT)
    Patel, Gargi Surendra
    Ullah, Shahid
    Beeke, Carol
    Hakendorf, Paul
    Padbury, Rob
    Price, Timothy Jay
    Karapetis, Christos Stelios
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] The association between body mass index and postoperative complications, 30-day mortality and long-term survival in Dutch patients with colorectal cancer
    Arkenbosch, J. H. C.
    van Erning, F. N.
    Rutten, H. J.
    Zimmerman, D.
    de Wilt, J. H. W.
    Beijer, S.
    EJSO, 2019, 45 (02): : 160 - 166
  • [34] IMPACT OF DIABETES AND BODY MASS INDEX ON OUTCOMES IN PATIENTS WITH RESECTED COLORECTAL CANCER
    Castillo-Fernandez, Omar
    Ramos, Ivan
    ANNALS OF ONCOLOGY, 2011, 22 : v123 - v123
  • [35] Association of Body Mass Index with Survival Outcome in Patients with Head and Neck Cancer Treated with Combined Modality Therapy
    Ma, S. J.
    Khan, M.
    Iovoli, A. J.
    Farrugia, M. K.
    Wooten, K. E.
    Gupta, V.
    Mcspadden, R.
    Kuriakose, M.
    Hicks, W. L.
    Platek, M. E.
    Singh, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E21 - E22
  • [36] Incidence of Sarcopenia and its relationship with Body Mass Index in colorectal cancer patients
    Alivizatos, V.
    Athanasopoulos, P.
    Panagidi, M.
    Kadjianis, F.
    Kanellopoulou, A.
    Mainas, N.
    ANNALS OF ONCOLOGY, 2016, 27 : 68 - 68
  • [37] THE INCIDENCE AND MORTALITY OF ENDOMETRIAL CANCER AND ITS ASSOCIATION WITH BODY MASS INDEX AND HUMAN DEVELOPMENT INDEX IN ASIAN POPULATION
    Khazaei, Z.
    Dehkordi, A. Hasanpour
    Amiri, M.
    Adineh, H. A.
    Sohrabivafa, M.
    Darvishi, I
    Dehghani, S. L.
    Goodarzi, E.
    WORLD CANCER RESEARCH JOURNAL, 2018, 5 (04)
  • [38] Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer
    Shahjehan, Faisal
    Merchea, Amit
    Cochuyt, Jordan J.
    Li, Zhuo
    Colibaseanu, Dorin T.
    Kasi, Pashtoon Murtaza
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [39] Body mass index and colorectal cancer screening.
    Zhu, K.
    Wu, H.
    Jatoi, I.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S106 - S106
  • [40] Body mass index and molecular subtypes of colorectal cancer
    Murphy, Neil
    Newton, Christina C.
    Song, Mingyang
    Papadimitriou, Nikos
    Hoffmeister, Michael
    Phipps, Amanda, I
    Harrison, Tabitha A.
    Newcomb, Polly A.
    Aglago, Elom K.
    Berndt, Sonja, I
    Brenner, Hermann
    Buchanan, Daniel D.
    Cao, Yin
    Chan, Andrew T.
    Chen, Xuechen
    Cheng, Iona
    Chang-Claude, Jenny
    Dimou, Niki
    Drew, David
    Farris, Alton B.
    French, Amy J.
    Gallinger, Steven
    Georgeson, Peter
    Giannakis, Marios
    Giles, Graham G.
    Gruber, Stephen B.
    Harlid, Sophia
    Hsu, Li
    Huang, Wen-Yi
    Jenkins, Mark A.
    Laskar, Ruhina S.
    Le Marchand, Loic
    Limburg, Paul
    Lin, Yi
    Mandic, Marko
    Nowak, Johnathan A.
    Obon-Santacana, Mereia
    Ogino, Shuji
    Qu, Conghui
    Sakoda, Lori C.
    Schoen, Robert E.
    Southey, Melissa C.
    Stadler, Zsofia K.
    Steinfelder, Robert S.
    Sun, Wei
    Thibodeau, Stephen N.
    Toland, Amanda E.
    Trinh, Quang M.
    Tsilidis, Kostas K.
    Ugai, Tomotaka
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (02): : 165 - 173